Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings.
Dario CattaneoSalvatore SollimaPaola MeravigliaLaura MilazzoDavide MinisciMarta FusiCarlo FiliceCristina GervasoniPublished in: Drugs in R&D (2020)
The management of HIV-positive liver transplant recipients in clinical practice is a complex task, where possibility of simplifying antiretroviral regimens must be balanced with the need to guarantee optimal immunosuppression and the finest treatment tolerability. A multidisciplinary approach involving physicians and clinical pharmacologists/pharmacists could help achieve this goal.
Keyphrases
- hiv positive
- antiretroviral therapy
- men who have sex with men
- hiv infected
- south africa
- human immunodeficiency virus
- hiv infected patients
- hiv aids
- hiv testing
- clinical practice
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- primary care
- prognostic factors
- open label
- combination therapy
- general practice